TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase

Abstract Background The aim of the present study was to investigate the potential effects of the 5,10,15,20‑tetrakis (1‑meth‑ ylpyridinium‑4‑yl) porphyrin (TMPyP4) on the proliferation and apoptosis of human cervical cancer cells and the underlying...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheng,Ming‑Jun, Cao,Yun‑Gui
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2017
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602017000100217
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602017000100217
record_format dspace
spelling oai:scielo:S0716-976020170001002172017-09-15TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinaseCheng,Ming‑JunCao,Yun‑Gui TMPyP4 p38 MAPK Human cervical cancer cells Proliferation Apoptosis Abstract Background The aim of the present study was to investigate the potential effects of the 5,10,15,20‑tetrakis (1‑meth‑ ylpyridinium‑4‑yl) porphyrin (TMPyP4) on the proliferation and apoptosis of human cervical cancer cells and the underlying mechanisms by which TMPyP4 exerted its actions. Results After human cervical cancer cells were treated with different doses of TMPyP4, cell viability was determined by 3‑(4,5‑dimethyl‑2‑thiazolyl)‑2,5‑diphenyl‑2‑H‑tetrazolium bromide (MTT) method, the apoptosis was observed by flow cytometry (FCM), and the expression of p38 mitogen‑activated protein kinase (MAPK), phosphated p38 MAPK (p‑p38 MAPK), capase‑3, MAPKAPK2 (MK‑2) and poly ADP‑ribose polymerase (PARP) was measured by Western blot analysis. The analysis revealed that TMPyP4 potently suppressed cell viability and induced the apoptosis of human cervical cancer cells in a dose‑dependent manner. In addition, the up‑regulation of p‑p38 MAPK expression levels was detected in TMPyP4‑treated human cervical cancer cells. However, followed by the block of p38 MAPK signaling pathway using the inhibitor SB203580, the effects of TMPyP4 on proliferation and apoptosis of human cervical cancer cells were significantly changed. Conclusions It was indicated that TMPyP4‑inhibited proliferation and ‑induced apoptosis in human cervical cancer cells was accompanied by activating the p38 MAPK signaling pathway. Taken together, our study demonstrates that TMPyP4 may represent a potential therapeutic method for the treatment of cervical carcinoma.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.50 20172017-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602017000100217en10.1186/s40659-017-0129-4
institution Scielo Chile
collection Scielo Chile
language English
topic TMPyP4
p38 MAPK
Human cervical cancer cells
Proliferation
Apoptosis
spellingShingle TMPyP4
p38 MAPK
Human cervical cancer cells
Proliferation
Apoptosis
Cheng,Ming‑Jun
Cao,Yun‑Gui
TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
description Abstract Background The aim of the present study was to investigate the potential effects of the 5,10,15,20‑tetrakis (1‑meth‑ ylpyridinium‑4‑yl) porphyrin (TMPyP4) on the proliferation and apoptosis of human cervical cancer cells and the underlying mechanisms by which TMPyP4 exerted its actions. Results After human cervical cancer cells were treated with different doses of TMPyP4, cell viability was determined by 3‑(4,5‑dimethyl‑2‑thiazolyl)‑2,5‑diphenyl‑2‑H‑tetrazolium bromide (MTT) method, the apoptosis was observed by flow cytometry (FCM), and the expression of p38 mitogen‑activated protein kinase (MAPK), phosphated p38 MAPK (p‑p38 MAPK), capase‑3, MAPKAPK2 (MK‑2) and poly ADP‑ribose polymerase (PARP) was measured by Western blot analysis. The analysis revealed that TMPyP4 potently suppressed cell viability and induced the apoptosis of human cervical cancer cells in a dose‑dependent manner. In addition, the up‑regulation of p‑p38 MAPK expression levels was detected in TMPyP4‑treated human cervical cancer cells. However, followed by the block of p38 MAPK signaling pathway using the inhibitor SB203580, the effects of TMPyP4 on proliferation and apoptosis of human cervical cancer cells were significantly changed. Conclusions It was indicated that TMPyP4‑inhibited proliferation and ‑induced apoptosis in human cervical cancer cells was accompanied by activating the p38 MAPK signaling pathway. Taken together, our study demonstrates that TMPyP4 may represent a potential therapeutic method for the treatment of cervical carcinoma.
author Cheng,Ming‑Jun
Cao,Yun‑Gui
author_facet Cheng,Ming‑Jun
Cao,Yun‑Gui
author_sort Cheng,Ming‑Jun
title TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
title_short TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
title_full TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
title_fullStr TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
title_full_unstemmed TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
title_sort tmpyp4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
publisher Sociedad de Biología de Chile
publishDate 2017
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602017000100217
work_keys_str_mv AT chengming8209jun tmpyp4exertedantitumoreffectsinhumancervicalcancercellsthroughactivationofp38mitogenactivatedproteinkinase
AT caoyun8209gui tmpyp4exertedantitumoreffectsinhumancervicalcancercellsthroughactivationofp38mitogenactivatedproteinkinase
_version_ 1718441562374930432